Pier 88 Investment Partners’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-26,415
| Closed | -$84.8K | – | 97 |
|
2024
Q1 | $84.8K | Buy |
26,415
+1,620
| +7% | +$5.2K | 0.02% | 100 |
|
2023
Q4 | $121K | Sell |
24,795
-51,700
| -68% | -$253K | 0.03% | 90 |
|
2023
Q3 | $417K | Buy |
76,495
+4,870
| +7% | +$26.5K | 0.1% | 78 |
|
2023
Q2 | $481K | Hold |
71,625
| – | – | 0.12% | 76 |
|
2023
Q1 | $632K | Buy |
71,625
+14,420
| +25% | +$127K | 0.15% | 65 |
|
2022
Q4 | $437K | Hold |
57,205
| – | – | 0.11% | 69 |
|
2022
Q3 | $407K | Buy |
57,205
+1,940
| +4% | +$13.8K | 0.1% | 78 |
|
2022
Q2 | $447K | Buy |
55,265
+33,660
| +156% | +$272K | 0.11% | 82 |
|
2022
Q1 | $300K | Sell |
21,605
-10,870
| -33% | -$151K | 0.11% | 73 |
|
2021
Q4 | $911K | Buy |
32,475
+14,050
| +76% | +$394K | 0.19% | 77 |
|
2021
Q3 | $626K | Sell |
18,425
-10,337
| -36% | -$351K | 0.19% | 83 |
|
2021
Q2 | $1.18M | Buy |
28,762
+11,900
| +71% | +$486K | 0.34% | 71 |
|
2021
Q1 | $679K | Sell |
16,862
-1,110
| -6% | -$44.7K | 0.23% | 80 |
|
2020
Q4 | $1.06M | Sell |
17,972
-6,670
| -27% | -$394K | 0.34% | 56 |
|
2020
Q3 | $1.2M | Buy |
24,642
+11,732
| +91% | +$570K | 0.36% | 61 |
|
2020
Q2 | $625K | Buy |
+12,910
| New | +$625K | 0.18% | 88 |
|